1. Home
  2. IMO vs DXCM Comparison

IMO vs DXCM Comparison

Compare IMO & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMO
  • DXCM
  • Stock Information
  • Founded
  • IMO 1880
  • DXCM 1999
  • Country
  • IMO Canada
  • DXCM United States
  • Employees
  • IMO N/A
  • DXCM N/A
  • Industry
  • IMO Integrated oil Companies
  • DXCM Medical/Dental Instruments
  • Sector
  • IMO Energy
  • DXCM Health Care
  • Exchange
  • IMO Nasdaq
  • DXCM Nasdaq
  • Market Cap
  • IMO 32.4B
  • DXCM 27.7B
  • IPO Year
  • IMO N/A
  • DXCM 2005
  • Fundamental
  • Price
  • IMO $68.87
  • DXCM $71.66
  • Analyst Decision
  • IMO Hold
  • DXCM Strong Buy
  • Analyst Count
  • IMO 3
  • DXCM 18
  • Target Price
  • IMO $105.50
  • DXCM $99.00
  • AVG Volume (30 Days)
  • IMO 567.4K
  • DXCM 4.9M
  • Earning Date
  • IMO 05-02-2025
  • DXCM 05-01-2025
  • Dividend Yield
  • IMO 2.62%
  • DXCM N/A
  • EPS Growth
  • IMO 6.36
  • DXCM 9.35
  • EPS
  • IMO 6.28
  • DXCM 1.42
  • Revenue
  • IMO $35,802,451,974.00
  • DXCM $4,033,000,000.00
  • Revenue This Year
  • IMO $9.82
  • DXCM $16.39
  • Revenue Next Year
  • IMO $1.57
  • DXCM $15.64
  • P/E Ratio
  • IMO $10.96
  • DXCM $50.32
  • Revenue Growth
  • IMO 1.21
  • DXCM 11.34
  • 52 Week Low
  • IMO $58.76
  • DXCM $57.52
  • 52 Week High
  • IMO $80.17
  • DXCM $138.81
  • Technical
  • Relative Strength Index (RSI)
  • IMO 55.63
  • DXCM 55.27
  • Support Level
  • IMO $60.66
  • DXCM $65.11
  • Resistance Level
  • IMO $68.95
  • DXCM $69.69
  • Average True Range (ATR)
  • IMO 2.96
  • DXCM 3.45
  • MACD
  • IMO 0.70
  • DXCM 1.08
  • Stochastic Oscillator
  • IMO 96.75
  • DXCM 88.13

About IMO Imperial Oil Limited

Imperial Oil Ltd is an integrated oil company active in all phases of the petroleum industry in Canada, including the exploration for, and production and sale of, crude oil, natural gas, petroleum products, and petrochemicals. It also pursues lower-emission business opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, and lithium. The company's reportable segments are Upstream, Downstream, and Chemical. Maximum revenue for the company is generated from its Downstream segment, which refines crude oil into petroleum products and distributes and market these products. The Upstream segment explores and produces crude oil, its equivalents, and natural gas, and the Chemical segment manufactures and markets hydrocarbon-based chemicals and chemical products.

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: